Exhibit 99.1 Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update — Delivered $1.0 Million of Operating Income in Q3 2025 — SAN DIEGO, CA, November 13, 2025 — Women's health innovator Evofem Biosciences, Inc. (Evofem or the Company) (OTCID: EVFM), today announced financial results for the three- and nine-month periods ended September 30, 2025 and provided a business update. "Sales rebounded in the third quarter and were 10% higher than the same quarter last year, reflecting t ...